🔗 Permalink

Inventor profile of:

Deepank Utkhede

City:

Surrey

Country:

Canada

Published Applications:

Last publication date:

2023-03-23

Top Assignees for applications by Deepank Utkhede

The entities that hold a legal rights for patent applications filed by inventor Utkhede Deepank:

MATI THERAPEUTICS, INC. 7 Austin, TX United States
QLT PLUG DELIVERY, INC. 2 Menlo Park, CA United States
QLT INC. 1 Vancouver, Canada
QLT Plug Delivery, Inc. -QPDI 1 Menlo Park, CA United States
Mati Therapeutics 1 Austin, TX United States

Recent patent applications by Utkhede Deepank

Deepank Utkhede from Surrey, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-03-23

US20230091568A1

Human necessities

Ophthalmic drug sustained release formulation and uses thereof

#2 | 2021-01-28

US20210023165A1

Human necessities

OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES FOR DRY EYE SYNDROME TREATMENT

#3 | 2020-10-15

US20200323685A1

Human necessities

SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION

#4 | 2019-03-28

US20190091066A1

Human necessities

Drug Delivery System and Methods of Treating Open Angle Glaucoma and Ocular Hypertension

#5 | 2017-07-20

US20170202853A1

Human necessities

Sustained release delivery of active agents to treat glaucoma and ocular hypertension

#6 | 2014-11-27

US20140350103A1

Human necessities

Sustained release delivery of active agents to treat glaucoma and ocular hypertension

#7 | 2014-07-03

US20140186420A1

Human necessities

DRUG CORES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS

#8 | 2014-01-23

US20140025022A1

Human necessities

Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

#9 | 2013-10-31

US20130289089A1

Human necessities

Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof

#10 | 2013-02-28

US20130053794A1

Human necessities

SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION

#11 | 2012-07-26

US20120187594A1

Human necessities

Drug cores for sustained release of therapeutic agents

#12 | 2010-08-19

US20100209477A1

Human necessities

SUSTAINED RELEASE DELIVERY OF ONE OR MORE AGENTS

#13 | 2010-07-29

US20100189766A1

Human necessities

SUBSTANCE DELIVERING PUNCTUM IMPLANTS AND METHODS

#14 | 2009-04-23

US20090104243A1

Human necessities

Drug cores for sustained release of therapeutic agents

InventorID:

117269 ⎘